SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edscharp who wrote (681)5/12/1999 1:48:00 PM
From: DJ   of 1139
 
Bill Gates' interest in biotech is a combination of financial, intellectual, and philanthropic. He's interested in being a "technology visionary," so I see his ICOS investment and board membership as a way to learn more about this technology and the industry. Who could be a better mentor than Rathmann--who understands the science, the business, and the Washington regulatory scene and the Wall Street biotech crowd?

BillG also knows that this business is likely going to do very important things in the next few decades. I see Rathmann (and Lee Hood at the University of Washington--who holds the Gates Chair) as mentors.

Bottom line: I read Gates' ICOS investment as distinctly more than financial--he's interested in the science too (and also in humanitarian opportunities stemming from this industry's development).

One final point: Rathmann is discussed in some detail in the book "Corporate Creativity" by Robinson and Stern--with regard to how he managed R&D at 3M (his role in the development of Scotchgard). There's no question that Rathmann is an R&D icon from which other companies, even BillG, can learn a lot.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext